Corrigendum to "Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases"

J Diabetes Res. 2022 Apr 1:2022:3952529. doi: 10.1155/2022/3952529. eCollection 2022.

Abstract

[This corrects the article DOI: 10.1155/2012/902917.].

Publication types

  • Published Erratum